Breast Tubular Carcinoma — Trials

Breast Tubular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: RenJi Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02682693	Denosumab as an add-on Neoadjuvant Treatment (GeparX)(GeparX)	completed	Phase 2	780	GBG Forschungs GmbHOTHER	1	Feb 2, 2021	clinicaltrials
NCT02199418	Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer(SHPD001)	completed	Phase 2	132	RenJi HospitalOTHER	1	Jan 25, 2017	clinicaltrials